Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial

Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed sponsor/institution attributions for 'Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine' and 'Washington University School of Medicine', and the 'Helpful Links Provided by' section from the page.
    Difference
    0.2%
    Check dated 2025-10-27T20:47:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.
    Difference
    4%
    Check dated 2025-10-06T05:59:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Term change from Plasma cell myeloma to Multiple myeloma and an upgrade of revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T03:12:54.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Version bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:04.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T17:04:31.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location in St. Louis, Missouri, along with a range of medical terms related to plasma cell myeloma and stem cell transplantation. Several previous terms and references have been removed, indicating a shift in focus towards specific therapies and treatments.
    Difference
    7%
    Check dated 2025-08-31T12:12:42.000Z thumbnail image

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.